Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Juglanin
Cat. No.:
OB0225LY-0284
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Juglanin is a JNK activator with inflammation and anti-tumor activities.
Synonym:
5041-67-8; Kaempferol 3-arabinofuranoside; Euglanin; 3-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 3-(((2S,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; Kaempferol 3-a-L-arabinofuranoside; 4H-1-Benzopyran-4-one, 3-(alpha-L-arabinofuranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-
CAS No.:
5041-67-8
Compound CID:
5318717
Formula:
C20H18O10
Formula Weight:
418.35
Specification
Relative Density:
1.76 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Juglanin can be used in anti-tumor research or play an important role in antioxidant research.
Library Information
Targets:
MAPK family
Receptors:
Apoptosis; Autophagy; JNK
Pathways:
Apoptosis; Autophagy; MAPK
Plate Number:
AOCL-4
Plate Location:
f3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
20 mg/mL; 47.80 mM
Special Max Solubility:
M16 mg/mL
